Genesee Capital Advisors LLC Raises Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Genesee Capital Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,091 shares of the healthcare conglomerate’s stock after acquiring an additional 101 shares during the period. Genesee Capital Advisors LLC’s holdings in UnitedHealth Group were worth $552,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. M&T Bank Corp increased its holdings in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC grew its stake in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. lifted its holdings in shares of UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new position in UnitedHealth Group in the 3rd quarter valued at $21,165,000. Finally, Signal Advisors Wealth LLC boosted its holdings in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $542.52 on Wednesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The business’s 50-day simple moving average is $540.11 and its 200-day simple moving average is $565.06. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $499.27 billion, a P/E ratio of 35.00, a P/E/G ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the firm earned $5.83 EPS. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on UNH. KeyCorp reissued an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.